Osteoarthritis is the most common type of joint disease, affecting more than 20 million individuals in the United states alone. It represents a heterogeneous group of conditions resulting in common histopathologic and radiologic changes. It can be thought of as a degenerative disorder arising from a biochemical breakdown of articular (hyaline cartilage in the synovial joints). However the current view holds that osteoarthritis involves not only the articular cartilage but also the entire joint organ, including the subchondral bone and synovium.
RCT is using proteins, peptides, growth factors and polyphenols that are carrying encoded information to specific type of receptor on membrane a particular type of cell. This creates a series of intercellular reactions.
The signals pass through the nucleus of the cell until they arrive to the DNA. These signals stimulate the DNA. When this process is complete the RNA reads the new information and creates a functional protein based on the needs of that particular cell. This causes the cell to start functioning normally again.
Polyphenols and Flavonoids, which are a family of Polyphenols, are an addition to the protocol when RCT is treating patients with autoimmune disorders where inflammation is present. Flavonoids can selectively inhibit cell-signals by binding to specific receptors in cell membranes, helping to regulate cell proliferation, inflammation, invasion, metastasis, and activation of apoptosis.
Regenerative Cellular Therapy’s protocol for Osteoarthritis will strengthen the body’s immune system, as well as provide specific proteins and peptides for muscle, tendon, and bone cells. When the patient’s immune system stops attacking the patient’s body and the cells can begin functioning normally, the muscle tendon and bone are able to start the process of regeneration.